When Wegovy peaks in your system — and why the timing matters

Why peaking in 24–72 hours is the decision your body keeps making

Every week, roughly a day to three days after your injection, semaglutide reaches its highest concentration in the bloodstream. This is not an abrupt spike and crash, the curve is relatively shallow because semaglutide is absorbed slowly from the tissue under the skin. Think of it less like a wave breaking and more like a slow tide coming in, then gently receding.

That peak is where appetite suppression tends to be strongest. For many people, the day or two following an injection is when hunger feels most noticeably reduced and portion sizes shrink without much effort. The week then softens gradually, so by the time the next injection is due, some people feel hunger beginning to return slightly. This is normal and expected, it is not the medicine failing.

Semaglutide's half-life is around one week, meaning that after seven days approximately half the absorbed dose remains active. Because doses are given weekly before levels drop too low, the medicine accumulates steadily. You can read more about how Wegovy builds up in your system and what that means in practice. The NHS patient information for semaglutide describes this pharmacokinetic profile clearly for anyone who wants the clinical detail.

One practical note: if you tend to inject on a Monday morning, for example, Tuesday and Wednesday are often the days the medicine is working hardest. Knowing that can help you plan meals and activity around when appetite suppression is at its peak rather than being caught off guard.

Steady state, the point at which the curve stabilises

The peak after a single dose is only part of the picture. Because semaglutide lingers for so long, each weekly injection adds to what is already present. Over the first four to five weeks of treatment, blood levels rise cumulatively until input and clearance balance out. This equilibrium is called steady state, and it is where the medicine's full effect tends to become consistent.

Before steady state, the week-to-week experience can feel uneven. Some people notice the medicine feels stronger in weeks three or four than it did in week one, that is accumulation at work, not a change in dose. Once steady state is reached, the peak-to-trough variation each week settles into a predictable pattern.

The dose titration schedule (starting low and increasing gradually) means steady state is reset slightly each time a new dose is introduced. This is one reason prescribers space dose increases several weeks apart: it gives the body time to reach equilibrium at each level before moving higher. For a broader look at the pharmacology, our page on how Wegovy stays in your system for a week goes into the mechanics in more detail.

If you are curious about the parallel picture for the active ingredient across all its formulations, the semaglutide peak timing page covers the comparison between injectable and oral forms.

What the peak curve means for side effects

Nausea, the most commonly reported side effect of Wegovy, tends to cluster around the peak concentration window. For many people that means the first day or two after an injection can feel unsettled, particularly after a dose increase, and then things ease. By the time the next injection is due, the GI discomfort has often passed entirely.

This timing pattern is why the semaglutide overview and the NHS guidance both emphasise that side effects are usually most prominent after starting treatment or stepping up a dose, they are concentration-driven, not random. Knowing that nausea at day two does not mean day fourteen will feel the same way is genuinely reassuring for most people.

In January 2026, the MHRA issued a Drug Safety Update reminding prescribers and patients that acute pancreatitis is a known but infrequent side effect of GLP-1 medicines. Severe, persistent stomach pain that reaches into the back (with or without vomiting) needs prompt medical attention, not a wait-and-see approach. That is distinct from the transient nausea that tracks the peak curve. If you are ever unsure which category your symptoms fall into, contact a clinician rather than waiting.

The Wegovy clearance page covers what happens at the other end of the curve (how long the medicine takes to leave your system entirely if treatment stops) which is useful context alongside the peak question. You can also report any suspected side effects through the MHRA's Yellow Card scheme, which exists specifically to capture real-world safety signals.

Fitting this knowledge into your decision about treatment

Understanding peak timing is one piece of deciding how Wegovy fits into your life. If you know the 24–72 hour window is when appetite suppression is strongest, you can choose an injection day that aligns with your week, injecting on a Thursday if weekends are when you want the most support with eating, for instance, or on a Monday if structure around the working week suits you better.

It also helps with setting realistic expectations. The first few weeks, before steady state, can feel inconsistent. That inconsistency has a physiological explanation, and it tends to resolve.

Wegovy is a prescription-only medicine. What the peak curve looks like for you personally (how strongly you feel it, when side effects cluster, how appetite shifts) is something your prescriber factors into ongoing review. If you are thinking about starting treatment, our Wegovy treatment page covers eligibility and the full process, and you can also get a sense of what Wegovy costs privately in the UK before making any decisions. When you are ready, speaking to our prescribers is the natural next step.